Jena Lilly has over a decade of leadership in pediatric research operations, with a singular focus on building collaborative systems that accelerate cures. As Executive Director of CBTN, she oversees the strategic and operational growth of one of the world’s largest open-access pediatric brain tumor research initiatives. Under her guidance, CBTN has expanded our global network, enhanced our infrastructure for data and specimen sharing, and launched transformative programs that keep patient impact at the center of every effort. Jena leads with a deep commitment to transparency, equity, and partnership, ensuring every family’s contribution drives real progress.
